Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia

[1]  D. Niederwieser,et al.  Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia. , 1985, Onkologie.

[2]  C. Schmidt,et al.  Treatment of hairy-cell leukemia with recombinant leukocyte A interferon. , 1985, Onkologie.

[3]  J. Melo,et al.  Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. , 1984, Seminars in oncology.

[4]  F. Sigaux,et al.  Hairy cell leukemia: clinical presentation and follow-up of 211 patients. , 1984, Seminars in oncology.

[5]  G. Tricot,et al.  Prognosis and therapy in hairy cell leukemia. , 1984, Seminars in oncology.

[6]  A. Thompson.  Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis. , 1984, Blood.

[7]  B. Haynes,et al.  Human erythrocyte antigens: II. The In(Lu) gene regulates expression of an antigen on an 80-kilodalton protein of human erythrocytes. , 1984, Blood.

[8]  D. Wagner,et al.  Irradiation induces release of von Willebrand protein from endothelial cells in culture , 1984 .

[9]  R. Holdrinet,et al.  TREATMENT OF HAIRY-CELL LEUKAEMIA WITH RECOMBINANT HUMAN α2-INTERFERON , 1984, The Lancet.

[10]  J. Manning,et al.  Alpha interferon for induction of remission in hairy-cell leukemia. , 1984, The New England journal of medicine.

[11]  M. Grimm,et al.  High and Low Dose Treatment for High and Low Grade Non-Hodgkin’s Lymphoma , 1985 .

[12]  K. Cantell,et al.  Production and preparation of human leukocyte interferon , 1977 .